Trial Profile
A Double Blind, Placebo Controlled, Crossover Design, Multicenter Study of Intravenous Ferumoxytol Compared With Placebo
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Sep 2014
Price :
$35
*
At a glance
- Drugs Ferumoxytol (Primary)
- Indications Anaemia
- Focus Adverse reactions
- Sponsors AMAG Pharmaceuticals
- 15 Sep 2014 New trial record